A Randomised Phase II Trial of Osimertinib with or without Stereotactic Radiosurgery for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases
- Alamgeer, Muhammad (Primary Chief Investigator (PCI))
- Parakh, Sagun (Chief Investigator (CI))
Project: Research